Compared with other glucose‐lowering drugs, GLP‐1 RAs ‐ because of their glucose‐dependent mode of action ‐ are associated with low risk of hypoglycaemia, an important consideration in older persons with T2D. The gene discussed is GCG; the disease is type 2 diabetes mellitus.